Joshua Amimo | Virology and Immunology | Best Researcher Award

Dr. Joshua Amimo | Virology and Immunology | Best Researcher Award

Research Scientist at The Ohio State University, United States

Dr. Joshua Oluoch Amimo is a renowned veterinary scientist and virologist specializing in animal genetics, swine viral diseases, and zoonotic infections. With a distinguished research career spanning over two decades, he has made significant contributions to the fields of immunology, molecular virology, and veterinary public health. Currently serving as a Research Scientist at The Ohio State University’s Center for Food Animal Health, Dr. Amimo is globally recognized for his work on mucosal and lactogenic immunity against swine enteric viruses and for his dedication to mentoring emerging scientists across Africa and the United States.

Profile

Scopus

Orcid

Education

Dr. Amimo earned his Ph.D. in Animal Genetics with a specialization in Infectious Disease Genetics and Virology through a collaborative program between the University of Nairobi and Ohio State University. His dissertation focused on the molecular detection, genetic characterization, and zoonotic potential of porcine rotaviruses. Prior to this, he completed his M.Sc. in Animal Genetics and Breeding at the University of Nairobi, where he examined the reproductive performance of Ayrshire cattle in Kenya. He also holds a Bachelor of Veterinary Medicine (BVM) from the same institution. Complementing his biological expertise, he earned a Google Data Analytics Certificate in 2024, gaining skills in SQL, R, machine learning, and data visualization.

Experience

Dr. Amimo’s career trajectory reflects a steady ascent through academic and research institutions. He has served as a Postdoctoral Researcher and Research Fellow at The Ohio State University and the BecA-ILRI Hub, leading studies on swine enteric viruses, antimicrobial resistance, and probiotic interventions in pig health. His academic roots trace back to his tenure as a lecturer at the University of Nairobi, where he instructed undergraduate and postgraduate courses in molecular genetics, virology, and immunology. He has led or collaborated in multiple large-scale international projects focused on One Health and zoonotic diseases, with administrative and mentorship roles in both Kenyan and U.S.-based institutions.

Research Interest

Dr. Amimo’s primary research interests lie in viral immunology, host-pathogen interactions, zoonotic disease transmission, and animal model-based vaccine evaluation. His work on porcine rotaviruses, porcine epidemic diarrhea virus (PEDV), and African swine fever integrates molecular biology, bioinformatics, and immunological assays to better understand viral replication and immunity. He is also passionate about developing and testing microbiota-based therapies, particularly probiotics, for use in livestock systems. His research aligns with broader One Health goals by investigating the cross-species transmission of pathogens and contributing to global food and public health security.

Award

Throughout his career, Dr. Amimo has garnered several prestigious fellowships and travel awards that underscore his research excellence. These include the African Bioscience Challenge Fund (ABCF) Fellowship, the VPH-Biotech Fellowship from Ohio State University, and multiple travel awards to present at conferences such as CRWAD, ICOPHAI, and the Global African Swine Fever Research Alliance (GARA). His academic performance was also supported by scholarships from the University of Nairobi and the Kenyan government during his undergraduate and graduate studies. These accolades highlight his sustained impact in veterinary virology, infectious diseases, and capacity building.

Publication

Dr. Amimo is the author of over 30 peer-reviewed journal articles and several book chapters. Highlighting seven notable works:

  1. Gut Pathogen (2025): “Stunting is associated with persistent and transferable alterations in the gut microbiome.”
  2. Frontiers in Immunology (2024): “Maternal immunization and Vitamin A sufficiency impact sow immunity to PEDV.”
  3. Viruses (2024): “Histo-Blood Group Antigen-Producing Bacterial Cocktail Reduces Rotavirus Infection.”
  4. Immuno (2023): “Deficient SARS-CoV-2 Immune Response and COVID-19 Mortality.”
  5. Frontiers in Immunology (2023): “Vitamin A affects T cell immune responses to rotavirus infection.”
  6. Gut Microbes (2023): “Intestinal mucin-type O-glycans in host-bacteria-rotavirus interactions.”
  7. Nutrients (2022): “Immune Impairment Associated with Vitamin A Deficiency.”
    These publications have been cited in key scientific literature, reflecting Dr. Amimo’s global influence in animal health research.

Conclusion

Dr. Joshua Oluoch Amimo exemplifies excellence in veterinary research, academic leadership, and global health advocacy. His interdisciplinary approach—spanning virology, immunology, bioinformatics, and animal husbandry—positions him as a pivotal figure in advancing livestock health and combating zoonotic threats. Through his numerous research collaborations, mentorship roles, and policy-informing projects, Dr. Amimo has significantly impacted the scientific community and public health. His body of work not only contributes to academic knowledge but also offers real-world applications in vaccine development, disease control, and sustainable animal production. These accomplishments make him an outstanding nominee for the Best Researcher Award in the biotechnology and animal health sectors.

Weiwei Chen | Infectious Diseases | Best Researcher Award

Prof. Weiwei Chen | infectious diseases | Best Researcher Award

Director Technician at Fifth Medical Center of Chinese PLA General Hospital, China

Weiwei Chen is a distinguished expert in infectious disease medicine, currently serving as the Director Technician and Deputy Director of the Institute of Infectious Disease Medicine at the Fifth Medical Center of the General Hospital of the People’s Liberation Army (PLA), China. With over three decades of experience in laboratory diagnostics and infectious disease control, she has become a vital figure in China’s medical defense infrastructure. Her leadership has been instrumental in managing large-scale epidemic responses, both domestically and internationally. Through her technical guidance, scholarly output, and fieldwork, Chen has demonstrated a sustained commitment to advancing public health, medical training, and disease surveillance, making her a leading candidate for recognition in the field of infectious disease research and control.

Profile

Scopus

Education

Chen’s educational foundation is rooted in medical diagnostics and epidemiology. She earned her bachelor’s degree in Laboratory Medicine from the Third Military Medical University in 1990, providing her with core clinical and laboratory skills. Pursuing further specialization, she obtained her master’s degree in Clinical Laboratory Diagnostics from the same university in 2001, which refined her expertise in pathogen detection and diagnostic methodologies. In 2007, she completed her doctoral studies in Infectious Diseases at the Chinese PLA Medical School, focusing on disease transmission dynamics and immunological responses to viral outbreaks. This progression illustrates her enduring commitment to scientific excellence and specialized knowledge.

Experience

Over the course of her professional career, Chen has assumed numerous technical and leadership roles, culminating in her current position as Deputy Director of the Institute of Infectious Disease Medicine at the PLA’s Fifth Medical Center. She oversees pathogen surveillance, laboratory operations, and technical training programs tailored to military and civilian health contingencies. Her field experience includes serving as the head of the fifth group of the Chinese Military Medical Expert Group (CMMEG) dispatched to Sierra Leone from 2019 to 2022. Under her leadership, the group made significant contributions to local COVID-19 mitigation strategies in collaboration with the Republic of Sierra Leone Armed Forces. Her proactive involvement in epidemic control and her capacity to translate scientific research into applied medical strategies underscore her value as a national and international asset in disease prevention.

Research Interest

Chen’s research centers on the immune mechanisms and therapeutic targets associated with high-impact infectious diseases such as COVID-19, influenza, and adenovirus. She has a deep interest in understanding how viral pathogens evade immune responses and identifying potential molecular interventions. In addition to this, she investigates the mechanisms of pathogen transmission in group settings, especially in military environments, aiming to create effective strategies for outbreak prediction and containment. Her work seamlessly integrates laboratory diagnostics, immunology, and field epidemiology to develop evidence-based responses to emerging public health threats.

Award

Weiwei Chen has been recognized with two Science and Technology Progress Awards by the Chinese PLA, highlighting her contributions to national health security and research excellence. Her leadership in international medical missions, particularly in Sierra Leone during the COVID-19 crisis, earned her high praise from the Sierra Leone Armed Forces. These honors underscore her commitment to public health, international collaboration, and the advancement of medical science in service of military and civilian populations alike.

Publication

Chen has published over 80 academic papers, including 17 in SCI-indexed journals. Selected key publications include:

  1. Immune profiling in severe COVID-19 patients (2020), Science Translational Medicine, cited by 350 articles.

  2. Clinical features of adenovirus pneumonia outbreaks (2021), Journal of Infection, cited by 112 articles.

  3. Pathogen detection using multiplex PCR in military cohorts (2022), Frontiers in Microbiology, cited by 75 articles.

  4. Strategies for laboratory biosafety in pandemic response (2019), Military Medical Research, cited by 63 articles.

  5. Comparative study on antiviral treatments in influenza (2021), Virology Journal, cited by 58 articles.

  6. Field diagnostics innovation during Ebola resurgence (2020), Tropical Medicine and Health, cited by 49 articles.

  7. Adjuvant therapy targets in viral pneumonia (2023), International Journal of Infectious Diseases, cited by 37 articles.
    These works collectively reflect her expertise in virology, diagnostic innovation, and field medicine.

Conclusion

Weiwei Chen’s professional journey exemplifies dedication to the advancement of infectious disease research, diagnostics, and international cooperation in public health emergencies. Her educational achievements, research contributions, and field leadership mark her as a pivotal figure in medical science, particularly in the strategic domains of epidemic preparedness and military medicine. Through a career characterized by scientific rigor and humanitarian service, she continues to impact global health security and stands as a compelling nominee for any award honoring excellence in infectious disease research and public health.